Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid‐range, and reduced left ventricular ejection fraction

AIMS: Patients with concomitant atrial fibrillation (AF) and reduced left ventricular ejection fraction (LVEF) have poor prognosis. Outcomes of novel oral anticoagulant (NOAC) in elderly AF patients with normal, mid‐range, and reduced LVEF were investigated. METHODS AND RESULTS: Data were retrieved...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ESC Heart Fail
Asıl Yazarlar: Wu, Victor Chien‐Chia, Wang, Chun‐Li, Lee, Cheng‐Hung, Chen, Yu‐Ling, Tu, Hui‐Tzu, Wu, Michael, Kuo, Chang‐Fu, Chen, Shao‐Wei, Huang, Yu‐Tung, Wen, Ming‐Shien, Chang, Shang‐Hung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Original Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524083/
https://ncbi.nlm.nih.gov/pubmed/32677373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12890
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller